Q&A With Mary Norine Walsh From St. Vincent Hospital: New Therapies Provide Hope for Heart Failure Patients

Video

With the introduction of two new medications cardiologists have powerful new tools to use in order to help heart failure become an even more manageable condition.

With the introduction of two new medications cardiologists have powerful new tools to use in order to help heart failure become an even more manageable condition.

Mary Norine Walsh, MD, from St. Vincent Hospital in Indianapolis discussed these new options as well as other areas of interest for the condition during the European Society of Cardiology's annual conference in London. In addition to her duties at the hospital Walsh also serves as the Vice President of the American College of Cardiology.

Whether it is the general practitioner, the cardiologist, or the cardiac surgeon, the landscape of heart failure treatment is constantly changing. Because of this learning remains an important factor in daily practice.

New medications and treatments for heart failure have been developed over the past couple of decades but there is still more work to be done. This includes improving existing technology and also adding new tools in the fight against the condition.

Recent Videos
How to Address Blistering Diseases, with Donna Culton, MD, PhD
Matthew Zirwas, MD: Discussing Upadacitinib, Other JAK Inhibitors for Atopic Dermatitis
Differentiating Between Different Types of Alopecia, with Jerry Shapiro, MD
Julie Harper, MD: Discussing Acne Treatment Updates, Unmet Needs Among Patients
Using Microbiomes to Diagnose Ventilator-Associated Pneumonia
Discussing Unmet Needs Among Patients in Dermatology, with Matthew Zirwas, MD
Review of Recent Advancements in Dermatology, with Matthew Zirwas, MD
Allison Moser, MSN, RN, FNP-BC | Credit: Allison Moser on LinkedIn
Raj Chovatiya, MD, PhD: Treating Hidradenitis Suppurativa with IL-17, JAK Inhibitors
Most Promising New Drugs for Hidradenitis Suppurativa, with Raj Chovatiya, MD, PhD
© 2024 MJH Life Sciences

All rights reserved.